Wanbangde Pharmaceutical Holding Group (002082.SZ) announced that the company has decided to invest its own funds to establish a wholly-owned subsidiary in Zhejiang Wanbangde Industrial...
According to the Zhiyuan Finance APP, Wanbangde Pharmaceutical Holding Group (002082.SZ) announced that the company has decided to invest its own funds to establish a wholly-owned subsidiary, Zhejiang Wanbangde Industrial and Trade Co., Ltd., with a registered capital of 10 million yuan. The company has obtained the business license issued by the Market Supervision Administration of Wenling City.
The announcement shows that the establishment of this wholly-owned subsidiary is mainly to further respond to the national Belt and Road Initiative Concept and to continuously promote the company’s Global Strategy of "bringing in and going out" for synergistic development with Africa. This strengthens the close connection with the health industry in Africa and enhances the company's overall strength in the big health industry.